Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Alan F List

1-50 of 293 results

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

scientific article

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

scientific article

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

scientific article published on 01 February 1997

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

scientific article

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

scientific article

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

scientific article published on December 1, 2001

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

scientific article

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

scientific article published on 2 August 2012

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

scientific article

Persistent malignant stem cells in del(5q) myelodysplasia in remission

scientific article

First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

scientific article published on 31 January 2011

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

scientific article

Applying synthetic lethality for the selective targeting of cancer.

scientific article published in October 2014

Induction of myelodysplasia by myeloid-derived suppressor cells.

scientific article

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies

scientific article

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

scientific article published on 19 August 2010

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

scientific article published on 10 January 2011

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.

scientific article

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

scientific article

Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes

scientific article published on 18 July 2007

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

scientific article published on 12 May 2008

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

scientific article published on 01 September 1993

Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase

scientific article published on 28 December 2010

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.

scientific article published on 14 March 2013

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling

scientific article published on 6 February 2013

Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.

scientific article published on 29 August 2006

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis

scientific article published on 01 July 1986

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

scientific article

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

scientific article published on August 22, 2012

The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.

scientific article

Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes

scientific article published on March 30, 2010

A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies.

scientific article

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

scientific article

GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.

scientific article

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

scientific article published on 13 October 2016

Myelodysplastic syndromes.

scientific article

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

scientific article published on April 12, 2013

Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome

scientific article published on 30 April 2012

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.

scientific article

Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report

scientific article

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.

scientific article published on 31 July 2015

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine

scientific article published on 12 February 2013

Underreporting of Myeloid Malignancies by United States Cancer Registries

scientific article published on January 11, 2012

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes

scientific article

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

scientific article

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

scientific article published on 26 January 2015

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

scientific article

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

scientific article published on 01 September 2000

Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.

scientific article

Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.

scientific article